Fondazione Policlinico Universitario Campus Bio-Medico

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

1 drugs in development

Preclinical1

By Therapeutic Area

top 1

Neurology

1100%

R&D Momentum

41/100

Pipeline Velocity

11/100

Trial Completion Rate

100/100

Pipeline Concentration

100/100

Pipeline Freshness

78/100

Activity

Recent Activity

Last 14 days

Sep 19, 2026

Completed

Prospective Randomized Comparative Evaluation of Different Chest Drainage Devices in Patients Undergoing Lung Lobectomy

Sep 18, 2026

Recruiting

The Effect of Noninvasive Brain Stimulation on Symptoms of Cervical Dystonia

Earlier

Sep 3, 2026TrialImproving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Prospective Real-life Observational Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity

Jul 17, 2026TrialAssociation of VAgus Nerve Stimulation and Treadmill Training for GAit Rehabilitation in DE Novo Parkinson's Disease (AVANTGARDE-PD)

Jun 24, 2026TrialBiophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer

Dec 19, 2024TrialOM 85 to Prevent Respiratory Infections in Older At Risk Patients

Jun 18, 2024TrialPotential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.

Jan 1, 2024TrialOnaBotulinumtoxin-A in Chronic Migraine Patients with Short or Long Disease History (the BACH Study)

4 more events

Apr 28, 2023TrialEffects Of Vitamin D On Bone, Muscle, And Adipose Tissue In Obese Subjects

Jan 4, 2022TrialREduced Pain After Bariatric Surgery - Gastric Bypass

Mar 22, 2021TrialEfficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD

Nov 3, 2019TrialEfficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Neurology

Migraine

OnabotulinumtoxinA OBT-A

Neurology

Migraine

OnabotulinumtoxinA OBT-APreclinical

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)